Korean Journal of Radiology

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

Lymphatic Intervention, the Frontline of Modern Lymphatic Medicine: Part II. Classification and Treatment of the Lymphatic Disorders

  • Saebeom Hur (Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Jinoo Kim (Department of Radiology, Ajou University Hospital) ;
  • Lakshmi Ratnam (Department of Radiology, St George's University Hospitals NHS Foundation Trust) ;
  • Maxim Itkin (Department of Radiology, Hospital of the University of Pennsylvania)
  • Received : 2022.09.13
  • Accepted : 2022.11.14
  • Published : 2023.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

Lymphatic disorders encompass a broad spectrum of diseases involving the lymphatic system, ranging from traumatic lymphatic leaks to lymphatic malformations. Lymphatic disorders can be categorized into traumatic and non-traumatic disorders according to their etiology. These two categories may be further divided into subgroups depending on the anatomical location of the lymphatic pathology and their association with clinical syndromes. Thoracic duct embolization was a milestone in the field of lymphatic intervention that encouraged the application of percutaneous embolization techniques to treat leaks and reflux disorders in the lymphatic system. Additional access routes for embolization, including retrograde thoracic duct and transhepatic lymphatic access, have also been developed. This article comprehensively reviews a variety of options for the treatment of lymphatic disorders, from conservative management to the most recent embolization techniques.

Keywords

Acknowledgement

This article was supported by grant no. 03-2022-0030 from the SNUH Research Fund.

References

  1. International Society for the Study of Vascular Anomalies. ISSVA classification of vascular anomalies. issva.org Web site. https://www.issva.org/classification. Accessed September 13, 2022 
  2. Faul JL, Berry GJ, Colby TV, Ruoss SJ, Walter MB, Rosen GD, et al. Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome. Am J Respir Crit Care Med 2012;161(3 Pt 1):1037-1046 
  3. Hilliard RI, McKendry JB, Phillips MJ. Congenital abnormalities of the lymphatic system: a new clinical classification. Pediatrics 1990;86:988-994 
  4. Itkin M. Interventional treatment of pulmonary lymphatic anomalies. Tech Vasc Interv Radiol 2016;19:299-304 
  5. Dori Y, Keller MS, Rome JJ, Gillespie MJ, Glatz AC, Dodds K, et al. Percutaneous lymphatic embolization of abnormal pulmonary lymphatic flow as treatment of plastic bronchitis in patients with congenital heart disease. Circulation 2016;133:1160-1170 
  6. Hur S, Jun H, Jeong YS. Novel interventional radiological management for lymphatic leakages after gynecologic surgery: lymphangiography and embolization. Gland Surg 2021;10:1260-1267 
  7. Kim SW, Hur S, Kim SY, Cho JY, Kwak C, Kim HS, et al. The efficacy of lymph node embolization using N-butyl cyanoacrylate compared to ethanol sclerotherapy in the management of symptomatic lymphorrhea after pelvic surgery. J Vasc Interv Radiol 2019;30:195-202.e1 
  8. Lee EW, Shin JH, Ko HK, Park J, Kim SH, Sung KB. Lymphangiography to treat postoperative lymphatic leakage: a technical review. Korean J Radiol 2014;15:724-732 
  9. Hur S, Shin JH, Lee IJ, Min SK, Min SI, Ahn S, et al. Early experience in the management of postoperative lymphatic leakage using lipiodol lymphangiography and adjunctive glue embolization. J Vasc Interv Radiol 2016;27:1177-1186.e1 
  10. Kwon LM, Hur S, Jeong CW, Jae HJ, Chung JW. Glue embolization of lymphopseudoaneurysm for chylous ascites after retroperitoneal surgery. Korean J Radiol 2020;21:376-383 
  11. Jun H, Hur S. Interventional radiology treatment for postoperative chylothorax. Korean J Thorac Cardiovasc Surg 2020;53:200-204 
  12. Jeon YJ, Cho JH, Hyun D, Shin S, Kim HK, Choi YS, et al. Management of chyle leakage after general thoracic surgery: impact of thoracic duct embolization. Thorac Cancer 2021;12:1382-1386 
  13. Kim PH, Tsauo J, Shin JH. Lymphatic interventions for chylothorax: a systematic review and meta-analysis. J Vasc Interv Radiol 2018;29:194-202.e4 
  14. Jun H, Hur S, Jeong YS, Kang CH, Lee H. Thoracic duct embolization in treating postoperative chylothorax: does bail-out retrograde access improve outcomes? Eur Radiol 2022;32:377-383 
  15. Nadolski GJ, Chauhan NR, Itkin M. Lymphangiography and lymphatic embolization for the treatment of refractory chylous ascites. Cardiovasc Intervent Radiol 2018;41:415-423 
  16. Lee S, Hur S, Jeong YS. Balloon-occluded retrograde transcatheter magnetic resonance lymphangiography to detect leakage in postoperative chylous ascites. J Vasc Interv Radiol 2021;32:617-619 
  17. Hur J, Hur S, Shin JH, Kwon SH, Hyun D, Yoon J. Reversed approach through lymphocele/lymphatic fluid collection for glue embolization of injured lymphatic vessels. J Vasc Interv Radiol 2021;32:299-304 
  18. Lee H, Kim SJ, Hur S, Kim HS, Min SI, Lee JH, et al. The feasibility of mesenteric intranodal lymphangiography: its clinical application for refractory postoperative chylous ascites. J Vasc Interv Radiol 2018;29:1290-1292 
  19. Sommer CM, Pieper CC, Offensperger F, Pan F, Killguss HJ, Koninger J, et al. Radiological management of postoperative lymphorrhea. Langenbecks Arch Surg 2021;406:945-969 
  20. Nadolski GJ, Itkin M. Thoracic duct embolization for nontraumatic chylous effusion: experience in 34 patients. Chest 2013;143:158-163 
  21. Hur S, Gurevich A, Nadolski G, Itkin M. Lymphatic interventional treatment for chyluria via retrograde thoracic duct access. J Vasc Interv Radiol 2021;32:896-900 
  22. Khaddash T, Nadolski G, Asher M, Itkin M. Successful diagnosis and treatment of protein-losing enteropathy using liver lymphangiography and embolization of hepatoduodenal lymphatic communications. J Vasc Interv Radiol 2020;31:1924-1926 
  23. Itkin M, Piccoli DA, Nadolski G, Rychik J, DeWitt A, Pinto E, et al. Protein-losing enteropathy in patients with congenital heart disease. J Am Coll Cardiol 2017;69:2929-2937 
  24. Kwon LM, Hur S, Kim KM, Im YJ, Ha J, Chung JW. Lymphatic embolization for primary chylous reflux of genitalia in 2 cases. J Vasc Interv Radiol 2019;30:1140-1143 
  25. Browse NL, Stewart G. Lymphoedema: pathophysiology and classification. J Cardiovasc Surg (Torino) 1985;26:91-106 
  26. Cho S, Atwood JE. Peripheral edema. Am J Med 2002;113:580-586 
  27. Keramida G, Winterman N, Wroe E, Aplin M, Peters AM. Importance of accurate ilio-inguinal quantification in lower extremity lymphoscintigraphy. Nucl Med Commun 2017;38:209-214 
  28. Weissleder H, Weissleder R. Lymphedema: evaluation of qualitative and quantitative lymphoscintigraphy in 238 patients. Radiology 1988;167:729-735 
  29. Witte CL, Witte MH, Unger EC, Williams WH, Bernas MJ, McNeill GC, et al. Advances in imaging of lymph flow disorders. Radiographics 2000;20:1697-1719 
  30. Arrive L, Derhy S, Dahan B, El Mouhadi S, Monnier-Cholley L, Menu Y, et al. Primary lower limb lymphoedema: classification with non-contrast MR lymphography. Eur Radiol 2018;28:291-300 
  31. Notohamiprodjo M, Weiss M, Baumeister RG, Sommer WH, Helck A, Crispin A, et al. MR lymphangiography at 3.0 T: correlation with lymphoscintigraphy. Radiology 2012;264:78-87 
  32. Yamamoto T, Yoshimatsu H, Narushima M, Yamamoto N, Hayashi A, Koshima I. Indocyanine green lymphography findings in primary leg lymphedema. Eur J Vasc Endovasc Surg 2015;49:95-102 
  33. Biko DM, Reisen B, Otero HJ, Ravishankar C, Victoria T, Glatz AC, et al. Imaging of central lymphatic abnormalities in Noonan syndrome. Pediatr Radiol 2019;49:586-592 
  34. Chavhan GB, Amaral JG, Temple M, Itkin M. MR lymphangiography in children: technique and potential applications. Radiographics 2017;37:1775-1790 
  35. Ozeki M, Fukao T. Generalized lymphatic anomaly and Gorham-Stout disease: overview and recent insights. Adv Wound Care (New Rochelle) 2019;8:230-245 
  36. John AS, Johnson JA, Khan M, Driscoll DJ, Warnes CA, Cetta F. Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation. J Am Coll Cardiol 2014;64:54-62 
  37. Mertens L, Hagler DJ, Sauer U, Somerville J, Gewillig M. Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group. J Thorac Cardiovasc Surg 1998;115:1063-1073 
  38. Dumont AE, Mulholland JH. Flow rate and composition of thoracic-duct lymph in patients with cirrhosis. N Engl J Med 1960;263:471-474 
  39. Ludwig J, Linhart P, Baggenstoss AH. Hepatic lymph drainage in cirrhosis and congestive heart failure. A postmortem lymphangiographic study. Arch Pathol 1968;86:551-562 
  40. Gurevich A, Hur S, Singhal S, DiBardino D, Haas AR, Hansen-Flaschen JH, et al. Nontraumatic chylothorax and chylopericardium: diagnosis and treatment using an algorithmic approach based on novel lymphatic imaging. Ann Am Thorac Soc 2022;19:756-762 
  41. Itkin MG, McCormack FX, Dori Y. Diagnosis and treatment of lymphatic plastic bronchitis in adults using advanced lymphatic imaging and percutaneous embolization. Ann Am Thorac Soc 2016;13:1689-1696 
  42. Bhatia C, Pratap U, Slavik Z. Octreotide therapy: a new horizon in treatment of iatrogenic chyloperitoneum. Arch Dis Child 2001;85:234-235 
  43. Bellini C, Cabano R, De Angelis LC, Bellini T, Calevo MG, Gandullia P, et al. Octreotide for congenital and acquired chylothorax in newborns: a systematic review. J Paediatr Child Health 2018;54:840-847 
  44. Dori Y, Smith C, Pinto E, Snyder K, March ME, Hakonarson H, et al. Severe lymphatic disorder resolved with MEK inhibition in a patient with Noonan syndrome and SOS1 mutation. Pediatrics 2020;146:e20200167 
  45. Li D, March ME, Gutierrez-Uzquiza A, Kao C, Seiler C, Pinto E, et al. ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor. Nat Med 2019;25:1116-1122 
  46. Srinivasa RN, Gemmete JJ, Osher ML, Hage AN, Chick JFB. Endolymphatic balloon-occluded retrograde abdominal lymphangiography (BORAL) and embolization (BORALE) for the diagnosis and treatment of chylous ascites: approach, technical success, and clinical outcomes. Ann Vasc Surg 2018;49:49-56 
  47. Mahrer A, Ramchandani P, Trerotola SO, Shlansky-Goldberg RD, Itkin M. Sclerotherapy in the management of postoperative lymphocele. J Vasc Interv Radiol 2010;21:1050-1053 
  48. Pieper CC, Hur S, Sommer CM, Nadolski G, Maleux G, Kim J, et al. Back to the future: lipiodol in lymphography-from diagnostics to theranostics. Invest Radiol 2019;54:600-615 
  49. O'Brien BM, Das SK, Franklin JD, Morrison WA. Effect of lymphangiography on lymphedema. Plast Reconstr Surg 1981;68:922-926 
  50. Luchtenberg M, Mikowski A, Schalnus R, Ungerechts R, Emmerich KH, Luchtenberg C. Erythematous eyelid swelling after dacryocystography. Perforation of the efferent lacrimal ducts in dacryocystography with contrast medium extravasation. Ophthalmologe 2000;97:894-895 
  51. Alejandre-Lafont E, Krompiec C, Rau WS, Krombach GA. Effectiveness of therapeutic lymphography on lymphatic leakage. Acta Radiol 2011;52:305-311 
  52. Gruber-Rouh T, Naguib NNN, Lehnert T, Harth M, Thalhammer A, Beeres M, et al. Direct lymphangiography as treatment option of lymphatic leakage: indications, outcomes and role in patient's management. Eur J Radiol 2014;83:2167-2171 
  53. Kawasaki R, Sugimoto K, Fujii M, Miyamoto N, Okada T, Yamaguchi M, et al. Therapeutic effectiveness of diagnostic lymphangiography for refractory postoperative chylothorax and chylous ascites: correlation with radiologic findings and preceding medical treatment. AJR Am J Roentgenol 2013;201:659-666 
  54. Kortes N, Radeleff B, Sommer CM, Bellemann N, Ott K, Richter GM, et al. Therapeutic lymphangiography and CT-guided sclerotherapy for the treatment of refractory lymphatic leakage. J Vasc Interv Radiol 2014;25:127-132 
  55. Kos S, Haueisen H, Lachmund U, Roeren T. Lymphangiography: forgotten tool or rising star in the diagnosis and therapy of postoperative lymphatic vessel leakage. Cardiovasc Intervent Radiol 2007;30:968-973 
  56. Matsumoto T, Yamagami T, Kato T, Hirota T, Yoshimatsu R, Masunami T, et al. The effectiveness of lymphangiography as a treatment method for various chyle leakages. Br J Radiol 2009;82:286-290 
  57. Haga M, Kato M, Kanno M, Shimizu M, Watanabe S. Lipiodol lymphangiography in a very low birth weight premature infant. J Pediatr Surg Case Rep 2020;58:101480 
  58. Gray M, Kovatis KZ, Stuart T, Enlow E, Itkin M, Keller MS, et al. Treatment of congenital pulmonary lymphangiectasia using ethiodized oil lymphangiography. J Perinatol 2014;34:720-722 
  59. Attar MA, Donn SM. Congenital chylothorax. Semin Fetal Neonatal Med 2017;22:234-239 
  60. Sommer CM, Pieper CC, Itkin M, Nadolski GJ, Hur S, Kim J, et al. Conventional lymphangiography (CL) in the management of postoperative lymphatic leakage (PLL): a systematic review. Rofo 2020;192:1025-1035 
  61. Nadolski GJ, Itkin M. Feasibility of ultrasound-guided intranodal lymphangiogram for thoracic duct embolization. J Vasc Interv Radiol 2012;23:613-616 
  62. Meisinger QC, O'Brien S, Itkin M, Nadolski GJ. Use of sequential pneumatic compression devices to facilitate propagation of contrast during intranodal lymphangiography. J Vasc Interv Radiol 2017;28:1544-1547 
  63. Schild HH, Pieper CC. Where have all the punctures gone? An analysis of thoracic duct embolizations. J Vasc Interv Radiol 2019;31:74-79 
  64. Kuetting D, Schild HH, Pieper CC. In vitro evaluation of the polymerization properties of N-butyl cyanoacrylate/iodized oil mixtures for lymphatic interventions. J Vasc Interv Radiol 2018;30:110-117 
  65. Cope C, Kaiser LR. Management of unremitting chylothorax by percutaneous embolization and blockage of retroperitoneal lymphatic vessels in 42 patients. J Vasc Interv Radiol 2002;13:1139-1148 
  66. Itkin M, Kucharczuk JC, Kwak A, Trerotola SO, Kaiser LR. Nonoperative thoracic duct embolization for traumatic thoracic duct leak: experience in 109 patients. J Thorac Cardiovasc Surg 2010;139:584-589; discussion 589-590 
  67. Mittleider D, Dykes TA, Cicuto KP, Amberson SM, Leusner CR. Retrograde cannulation of the thoracic duct and embolization of the cisterna chyli in the treatment of chylous ascites. J Vasc Interv Radiol 2008;19(2 Pt 1):285-290 
  68. Kariya S, Nakatani M, Ueno Y, Yoshida A, Ono Y, Maruyama T, et al. Transvenous retrograde thoracic ductography: initial experience with 13 consecutive cases. Cardiovasc Intervent Radiol 2018;41:406-414 
  69. Guevara CJ, Rialon KL, Ramaswamy RS, Kim SK, Darcy MD. US-guided, direct puncture retrograde thoracic duct access, lymphangiography, and embolization: feasibility and efficacy. J Vasc Interv Radiol 2016;27:1890-1896 
  70. Binkert CA, Yucel EK, Davison BD, Sugarbaker DJ, Baum RA. Percutaneous treatment of high-output chylothorax with embolization or needle disruption technique. J Vasc Interv Radiol 2005;16:1257-1262 
  71. Pamarthi V, Stecker MS, Schenker MP, Baum RA, Killoran TP, Suzuki Han A, et al. Thoracic duct embolization and disruption for treatment of chylous effusions: experience with 105 patients. J Vasc Interv Radiol 2014;25:1398-1404 
  72. Baek Y, Won JH, Kong TW, Paek J, Chang SJ, Ryu HS, et al. Lymphatic leak occurring after surgical lymph node dissection: a preliminary study assessing the feasibility and outcome of lymphatic embolization. Cardiovasc Intervent Radiol 2016;39:1728-1735 
  73. Chick JF, Reddy SN, Nadolski GJ, Dori Y, Itkin M. Single-session endolymphatic glue embolization of lymphocele after heart transplantation. J Vasc Interv Radiol 2016;27:929-930 
  74. Guez D, Nadolski GJ, Pukenas BA, Itkin M. Transhepatic lymphatic embolization of intractable hepatic lymphorrhea. J Vasc Interv Radiol 2014;25:149-150 
  75. Itou C, Koizumi J, Myojin K, Yamashita T, Mori N, Imai Y. A case of refractory chylous ascites after nephrectomy successfully treated with percutaneous obliteration using adhesive glue. Jpn J Radiol 2012;31:71-74 
  76. Ching KC, Santos E, McCluskey K, Jeyabalan G. CT-guided injection of N-butyl cyanoacrylate glue for treatment of chylous leak after aorto-mesenteric bypass. Cardiovasc Intervent Radiol 2013;37:1103-1106 
  77. Dinc H, Og˘uz S,, Sari A. A novel technique in the treatment of retroperitoneal lymphatic leakage: direct percutaneous embolization through the leakage pouch. Diagn Interv Radiol 2015;21:419-422 
  78. Baek Y, Won JH, Chang SJ, Ryu HS, Song SY, Yim B, et al. Lymphatic embolization for the treatment of pelvic lymphoceles: preliminary experience in five patients. J Vasc Interv Radiol 2016;27:1170-1176 
  79. Koehler PR. Complications of lymphography. Lymphology 1968;1:116-120 
  80. Bron KM, Baum S, Abrams HL. Oil embolism in lymphangiography. Incidence, manifestations, and mechanism. Radiology 1963;80:194-202 
  81. Dolan PA. Lymphography: complications encountered in 522 examinations. Radiology 1966;86:876-880 
  82. Bray DA, Brown CH 3rd, Herdt JR, DeVita VT. Loffler's syndrome as a complication of bipedal lymphangiography. JAMA 1970;214:369-371 
  83. Silvestri RC, Huseby JS, Rughani I, Thorning D, Culver BH. Respiratory distress syndrome from lymphangiography contrast medium. Am Rev Respir Dis 2015;122:543-549 
  84. Majdalany BS, Sanogo ML, Pabon-Ramos WM, Wilson KA, Goswami AK, Kokabi N, et al. Complications during lymphangiography and lymphatic interventions. Semin Intervent Radiol 2020;37:309-317 
  85. Gough MH. Lymphangiography in children. Arch Dis Child 1964;39:177-181 
  86. Chung JW, Park JH, Im JG, Han JK, Han MC. Pulmonary oil embolism after transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 1993;187:689-693 
  87. Hur S. Facing the truth: penetration of vital organs during thoracic duct embolization. J Vasc Interv Radiol 2020;31:80-81 
  88. Boffa DJ, Sands MJ, Rice TW, Murthy SC, Mason DP, Geisinger MA, et al. A critical evaluation of a percutaneous diagnostic and treatment strategy for chylothorax after thoracic surgery. Eur J Cardiothorac Surg 2008;33:435-439 
  89. Laslett D, Trerotola SO, Itkin M. Delayed complications following technically successful thoracic duct embolization. J Vasc Interv Radiol 2012;23:76-79